The analysis using Kaplan–Meier Plotter revealed a significant correlation between elevated IGF2BP3 levels and reduced overall survival (OS) (p = 0.006), disease-specific survival (DSS) (p = 0.012), and progression-free interval (PFI) (p = 0.001) in the TCGA BLCA dataset (Fig. 2A–C, Additional file 2: Fig.S2B). Here, IGF2BP3 is linked to bladder transitional cell carcinoma.